Search Results - "Greene, B M"

Refine Results
  1. 1

    Photon-number-discriminating detection using a quantum-dot, optically gated, field-effect transistor by Gansen, E. J, Rowe, M. A, Greene, M. B, Rosenberg, D, Harvey, T. E, Su, M. Y, Hadfield, R. H, Nam, S. W, Mirin, R. P

    Published in Nature photonics (01-10-2007)
    “…Detectors with the capability to directly measure the photon number of a pulse of light enable linear optics quantum computing, affect the security of quantum…”
    Get full text
    Journal Article
  2. 2

    Human infection by genetically diverse SIVSM-related HIV-2 in West Africa by FENG GAO, LING YUE, WHITE, A. T, PAPPAS, P. G, BARCHUE, J, HANSON, A. P, GREENE, B. M, SHARP, P. M, SHAW, G. M, HAHN, B. H

    Published in Nature (London) (06-08-1992)
    “…Our understanding of the biology and origins of human immunodeficiency virus type 2 (HIV-2) derives from studies of cultured isolates from urban populations…”
    Get full text
    Journal Article
  3. 3

    Characterization of the autoantigen calreticulin by Rokeach, LA, Haselby, JA, Meilof, JF, Smeenk, RJ, Unnasch, TR, Greene, BM, Hoch, SO

    Published in The Journal of immunology (1950) (01-11-1991)
    “…Anti-Ro/SS-A antibodies are commonly found in the sera of patients with Sjögren's syndrome and SLE. These antibodies also occur in the mothers of children with…”
    Get full text
    Journal Article
  4. 4

    The status of ivermectin in the treatment of human onchocerciasis by Taylor, H R, Greene, B M

    “…Ivermectin is a macrocyclic lactone that has widespread antiparasitic activity. Numerous clinical trials have shown that ivermectin is safe and effective in…”
    Get more information
    Journal Article
  5. 5

    Cell-mediated immune responses in human infection with Onchocerca volvulus by Gallin, M, Edmonds, K, Ellner, JJ, Erttmann, KD, White, AT, Newland, HS, Taylor, HR, Greene, BM

    Published in The Journal of immunology (1950) (15-03-1988)
    “…Mechanisms involved in modulation of the immune response in persons with chronic Onchocerca volvulus infection are poorly understood. In this study in vitro…”
    Get full text
    Journal Article
  6. 6

    Modern Medicine versus an Ancient Scourge: Progress toward Control of Onchocerciasis by Greene, Bruce M.

    Published in The Journal of infectious diseases (01-07-1992)
    “…Control of human onchocerciasis has been problematic. Vector control is practical and effective in only a circumscribed region of West Africa. Even in this…”
    Get full text
    Journal Article
  7. 7

    Isolation and characterization of expression cDNA clones encoding antigens on Onchocerca volvulus infective larvae by UNNASCH, T. R, GALLIN, M. Y, SOBOSLAY, P. T, ERTTMANN, K. D, GREENE, B. M

    Published in The Journal of clinical investigation (01-07-1988)
    “…The isolation of recombinant cDNA clones expressing antigens found in Onchocerca volvulus infective larvae is described. To isolate such clones, an expression…”
    Get full text
    Journal Article
  8. 8

    Prevalence of hypertension in rural west Africa by Giles, W H, Pacqué, M, Greene, B M, Taylor, H R, Muñoz, B, Cutler, M, Douglas, J

    “…The prevalence of hypertension in rural African communities has been reported previously to be relatively low, with prevalence rates ranging between 2.5% and…”
    Get more information
    Journal Article
  9. 9

    Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution by Pacqué, M, Muñoz, B, Poetschke, G, Foose, J, Greene, B M, Taylor, H R

    Published in The Lancet (British edition) (15-12-1990)
    “…Ivermectin is the drug of choice for community-based treatment of onchocerciasis. Since pregnancy testing during mass distribution campaigns is not feasible,…”
    Get more information
    Journal Article
  10. 10

    Ocular manifestations of onchocerciasis in a rain forest area of west Africa by Newland, H S, White, A T, Greene, B M, Murphy, R P, Taylor, H R

    Published in British journal of ophthalmology (01-03-1991)
    “…The epidemiology and natural history of onchocerciasis and its ocular complications in rain forest areas are poorly understood. The present study was conducted…”
    Get full text
    Journal Article
  11. 11

    Cellular killing of microfilariae of Onchocerca volvulus: eosinophil and neutrophil-mediated immune serum-dependent destruction by Greene, B M, Taylor, H R, Aikawa, M

    Published in The Journal of immunology (1950) (01-10-1981)
    “…A system that demonstrates in vitro cell-mediated killing of microfilariae of O. volvulus has been developed, using cryopreserved nodule material from endemic…”
    Get full text
    Journal Article
  12. 12

    A DNA sequence specific for forest form Onchocerca volvulus by Erttmann, K.D, Unnasch, T.R, Greene, B.M, Albiez, E.J, Boateng, J, Denke, A.M, Ferraroni, J.J, Karam, M, Schulz-Key, H, Williams, P.N

    Published in Nature (London) (04-06-1987)
    “…Onchocerciasis, or river blindness, is caused by infection with Onchocerca volvulus, a filarial parasite which infects about 40 million people in Africa and…”
    Get full text
    Journal Article
  13. 13

    Reliability of detection of microfilariae in skin snips in the diagnosis of onchocerciasis by Taylor, H R, Munoz, B, Keyvan-Larijani, E, Greene, B M

    “…To quantify the sensitivity of skin snips for the diagnosis of onchocerciasis, data collected over a 2 year period from 261 Liberians, 12-60 years of age, were…”
    Get more information
    Journal Article
  14. 14

    Experimental onchocerciasis in chimpanzees. Cell-mediated immune responses, and production and effects of IL-1 and IL-2 with Onchocerca volvulus infection by Soboslay, PT, Dreweck, CM, Taylor, HR, Brotman, B, Wenk, P, Greene, BM

    Published in The Journal of immunology (1950) (01-07-1991)
    “…Nine of eighteen chimpanzees inoculated with infective third-stage larvae of Onchocerca volvulus developed patent infection with microfilariae in skin…”
    Get full text
    Journal Article
  15. 15

    The effects of ivermectin on transmission of Onchocerca volvulus by Cupp, E.W, Bernardo, M.J, Kiszewski, A.E, Collins, R.C, Taylor, H.R, Aziz, M.A, Greene, B.M

    “…Ivermectin, given to onchocerciasis patients as a single oral dose of 200 micrograms per kilogram of body weight, substantially reduced the uptake of…”
    Get full text
    Journal Article
  16. 16

    Community-based treatment of onchocerciasis with ivermectin: acceptability and early adverse reactions by PACQUE, M. C, DUKULY, Z, GREENE, B. M, MUNOZ, B, KEYVAN-LARIJANI, E, WILLIAMS, P. N, TAYLOR, H. R

    Published in Bulletin of the World Health Organization (01-11-1989)
    “…A study of community-based treatment of onchocerciasis with ivermectin was undertaken in a rain forest area of Liberia to investigate the possible occurrence…”
    Get full text
    Journal Article
  17. 17

    Ivermectin prophylaxis against experimental Onchocerca volvulus infection in chimpanzees by Taylor, H R, Trpis, M, Cupp, E W, Brotman, B, Newland, H S, Soboslay, P T, Greene, B M

    “…Ivermectin was tested for possible prophylactic action against the third and fourth larval stages (L3 and L4) of Onchocerca volvulus inoculated into…”
    Get more information
    Journal Article
  18. 18

    Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis by Greene, B M, Taylor, H R, Cupp, E W, Murphy, R P, White, A T, Aziz, M A, Schulz-Key, H, D'Anna, S A, Newland, H S, Goldschmidt, L P

    Published in The New England journal of medicine (18-07-1985)
    “…We compared ivermectin with diethylcarbamazine for the treatment of onchocerciasis in a double-blind, placebo-controlled trial. Thirty men with moderate to…”
    Get more information
    Journal Article
  19. 19

    Safety of and compliance with community-based ivermectin therapy by Pacqué, M, Muñoz, B, Greene, B M, White, A T, Dukuly, Z, Taylor, H R

    Published in The Lancet (British edition) (09-06-1990)
    “…In a study of the safety, acceptability, and efficacy of ivermectin for community-based mass treatment of onchocerciasis, the drug was issued twice, one year…”
    Get more information
    Journal Article
  20. 20

    A Comparison of 6-, 12-, and 24-Monthly Dosing with Ivermectin for Treatment of Onchocerciasis by Greene, Bruce M., Dukuly, Zwannah D., Muñoz, Beatriz, White, Albert T., Pacque, Michel, Taylor, Hugh R.

    Published in The Journal of infectious diseases (01-02-1991)
    “…This study was designed to examine the optimal dose and interval of administration of ivermectin, the now-accepted drug of choice for onchocerciasis. Two…”
    Get full text
    Journal Article